Informovaný súhlas Sample Clauses

Informovaný súhlas. Zodpovedný skúšajúci získa od každej osoby zúčastňujúcej sa klinického skúšania (ďalej len „účastník klinického skúšania“) platný informovaný súhlas (ďalej len „informovaný súhlas“), podpísaný účastníkom klinického skúšania (ak EK nerozhodne, že takýto podpis sa nevyžaduje) a riadne zdokumentovaný. Inštitúcia/zodpovedný skúšajúci musia vykonávať klinické skúšanie spôsobom, ktorý je v súlade s informovaným súhlasom.
Sample 1
AutoNDA by SimpleDocs
Informovaný súhlas. Site shall obtain the prior written informed consent of each Study Subject prior to any Study procedure being performed. Site shall use an informed consent form that has been approved by Study Sponsor and is in accordance with Applicable Law and the requirements of the Institutional Review Board (“IRB”) or Independent Ethics Committee (“IEC”) that is responsible for reviewing the Study. Pracovisko skúšania sa zaväzuje použiť dokument informovaného súhlasu, ktorý bol schválený zadávateľom a spĺňa všetky platné nariadenia a požiadavky nezávislej etickej komisie, ktorá je zodpovedná za posúdenie skúšania. Pracovisko skúšania najprv získa od každého subjektu skúšania písomný informovaný súhlas.
Sample 1
Informovaný súhlas. Zdravotnícke zariadenie a hlavný skúšajúci zaistia, aby každý účastník skúšania riadne podpísal formulár informovaného súhlasu („ICF“), ktorý musí byť v súlade s príslušným zákonom, ako je schválený zadávateľom, poverencom zadávateľa (Syneos Health) a IEC, a ak je to vyžadované, aj príslušným orgánom, predtým než (i) je takýto účastník skúšania zaradený do skúšania a (ii) sa spracujú akékoľvek osobné údaje takéhoto účastníka skúšania.
Sample 1
Informovaný súhlas. 6.1 Skúšajúci bude zodpovedný za získanie podpísaného informovaného súhlasu od každého Účastníka klinickej štúdie ešte pred jeho účasíou v Klinickej štúdii.
Sample 1
Informovaný súhlas. 4.1 The Institution represents and warrants that it will obtain informed consent from each subject (or his/her legal representative) on a form approved by Sponsor and prior to such 4.1 Zdravotnícke zariadenie vyhlasuje a zaručuje, že od každého subjektu (alebo jeho zákonného zástupcu) získa informovaný súhlas na dokumente schválenom zadávateľom, a to pred subject’s enrollment in the Study and prior to the commencement of any Study-related procedure. The method of explanation to the subject (or his/her legal representative) and the obtaining of the consent should be conducted in accordance with all Applicable Regulations, Institutional Review Board and/or Ethics Committee (“IRB/EC”) instructions and is the responsibility of the Investigator. Each subject (or his/her legal representative) will be provided with a photocopy of his or her signed and dated informed consent form, the original of which shall be placed in the respective subject’s Study’s file. zaradením takéhoto subjektu do skúšania a skôr, než sa začne akýkoľvek postup súvisiaci so skúšaním. Spôsob vysvetlenia informácií subjektu (alebo jeho zákonnému zástupcovi) a získania súhlasu musí prebiehať v súlade so všetkými platnými predpismi a s pokynmi etickej komisie (ďalej „EK“) a zodpovedá zaň skúšajúci. Každému subjektu (alebo jeho zákonnému zástupcovi) sa poskytne fotokópia podpísaného a datovaného dokumentu informovaného súhlasu, ktorého originál bude uložený v zložke skúšania príslušného subjektu.
Sample 1
Informovaný súhlas. Institution acknowledges that Investigator shall use an informed consent form that has been approved by Sponsor and is in accordance with applicable regulations and the requirements of the Independent Ethics Committee (“IEC”) that is responsible for reviewing the Study. Zdravotnícke zariadenie potvrdzuje, že skúšajúci použije dokument informovaného súhlasu, ktorý bol schválený zadávateľom a spĺňa všetky platné nariadenia a požiadavky nezávislej etickej komisie, ktorá je zodpovedná za posúdenie skúšania.
Sample 1

Related to Informovaný súhlas

  • Investigatory Interview When the employee under investigation is to be interviewed concerning the alleged conduct which could result in discharge or other discipline, the employee and his or her representative shall be notified in writing, at least forty-eight (48) hours prior to the interview. In the event of an emergency, such reasonable notice as the circumstances permit shall be given. The notice shall state that an official investigation is being conducted and shall state the subject matter of the investigatory interview.

  • Investigatory Interviews When an employee is required by the City to attend an interview conducted by the City for purposes of investigating an incident which may lead to discipline/discharge of that employee because of that particular incident, the employee shall have the right to request that the employee be accompanied at the investigatory interview by a representative of the Union. If the employee makes such a request, the request shall be made to the City representative conducting the investigatory interview. The City, when faced with such a request, may:

  • Search, Enquiry, Investigation, Examination And Verification a. The Property is sold on an “as is where is basis” subject to all the necessary inspection, search (including but not limited to the status of title), enquiry (including but not limited to the terms of consent to transfer and/or assignment and outstanding charges), investigation, examination and verification of which the Purchaser is already advised to conduct prior to the auction and which the Purchaser warrants to the Assignee has been conducted by the Purchaser’s independent legal advisors at the time of execution of the Memorandum.

  • Complaints Investigation ‌ An employee who complains of harassment under the provisions of the Human Rights Code of British Columbia may refer the complaint to either one or other of the following processes:

  • Geotechnical Investigation Perform in accordance with the City Design Manual and other City requirements as designated in writing by the Director.

  • Investigational Services This plan covers certain experimental or investigational services as described in this section. Clinical Trials This plan covers clinical trials as required under R.I. General Law § 27-20-60. An approved clinical trial is a phase I, phase II, phase III, or phase IV clinical trial that is being performed to prevent, detect or treat cancer or a life-threatening disease or condition. In order to qualify, the clinical trial must be: • federally funded; • conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); or • a drug trial that is exempt from having such an investigational new drug application. To qualify to participate in a clinical trial: • you must be determined to be eligible, according to the trial protocol; • a network provider must have concluded that your participation would be appropriate; and • medical and scientific information must have been provided establishing that your participation in the clinical trial would be appropriate. If a network provider is participating in a clinical trial, and the trial is being conducted in the state in which you reside, you may be required to participate in the trial through the network provider. Coverage under this plan includes routine patient costs for covered healthcare services furnished in connection with participation in a clinical trial. The amount you pay is based on the type of service you receive. Coverage for clinical trials does not include: • the investigational item, device, or service itself; • items or services provided solely to satisfy data collection and that are not used in the direct clinical management; or • a service that is clearly inconsistent with widely accepted standards of care.

  • Business Representative You and your Representative individually affirm to Stripe that (a) your Representative is authorised to provide User Information on your behalf and to bind you to this Agreement; and (b) your Representative is an executive officer, director, senior manager or otherwise has significant responsibility for the control, management or direction of your business. Stripe may require you or your Representative to provide additional information or documentation demonstrating your Representative’s authority.

  • Grievance Investigations Where an employee has asked or is obliged to be represented by the Institute in relation to the presentation of a grievance and an employee acting on behalf of the Institute wishes to discuss the grievance with that employee, the employee and the representative of the employee will, where operational requirements permit, be given reasonable leave with pay for this purpose when the discussion takes place in the headquarters area of such employee and leave without pay when it takes place outside the headquarters area of such employee.

  • Supply Chain Monitoring A copy of the supply chain monitoring process, which should include details of the process for monitoring the financial viability of the supply chain (including timing), together with any known risks to supply chain stability and material changes to the supply chain. This should include extracts from Board level meetings, risk registers etc where any of the above items have been discussed. Annex 1 1 Information from Contractors who are not required to submit form AR01 to Companies House

  • Relationship Manager Inquiry for Actual Knowledge In addition to the electronic and paper record searches described above, the Reporting Financial Institution must treat as Reportable Accounts any High Value Accounts assigned to a relationship manager (including any accounts aggregated with such account) if the relationship manager, has actual knowledge that the Account Holder is a Specified Person.

Time is Money Join Law Insider Premium to draft better contracts faster.